Compare Docusign Inc (DOCU) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Docusign Inc vs DexCom, Inc. — how do they compare? Docusign Inc trades at $49.4 (market cap $9.52B), while DexCom, Inc. trades at $76.3 (market cap $29.46B). The key difference: DexCom, Inc. is far larger — about 3.1× Docusign Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Docusign Inc nearer its low. Which is the better fit depends on your goals.
| DOCU | DXCM | |
|---|---|---|
Market Cap | $9.52B | $29.46B |
Sector | Technology | Health |
52-Week High | $85.01 | $89.53 |
52-Week Low | $41.75 | $54.84 |
Enterprise Value | $8.89B | $28.43B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
